ON DEMAND FEMALE CONTRACEPTIVE

The present invention provides methods of female contraception, the methods comprising administering an effective amount of a combination of a progesterone receptor agonist and a cyclooxygenase-2 inhibitor in each of two doses, the first dose is administered within about 24 hours before or after a f...

Full description

Saved in:
Bibliographic Details
Main Authors DUFFY, Diane Marie, ARCHER, David Fitzgerald
Format Patent
LanguageEnglish
French
Published 27.10.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides methods of female contraception, the methods comprising administering an effective amount of a combination of a progesterone receptor agonist and a cyclooxygenase-2 inhibitor in each of two doses, the first dose is administered within about 24 hours before or after a first act of sexual intercourse and the second dose is administered between about 36 hours and about 60 hours after the first dose. La présente invention concerne des procédés de contraception féminine, les procédés comprenant l'administration d'une quantité efficace d'une combinaison d'un agoniste de récepteur de la progestérone et d'un inhibiteur de la cyclooxygénase-2 dans chacune de deux doses, la première dose étant administrée environ 24 heures avant ou après un premier acte sexuel et la seconde dose étant administrée entre environ 36 heures et environ 60 heures après la première dose.
Bibliography:Application Number: WO2022US25425